| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |